THE CANCER GENOME ATLAS Research Network, including more than 300 researchers from 44 institutions, found that molecular diagnostics are much more precise and reproducible than looking at tissue under a microscope for classification of diffuse gliomas.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
